strongly impaired at modified (for example, methylated) basic residues. Such missed cleavages increase peptide length and charge, resulting in complex fragmentation spectra that hinder identification of the peptide and methylation sites 2 . Lysine and arginine methylation is an important epigenetic and regulatory mechanism for protein-protein interactions and protein function in transcription, DNA repair and signaling 6 . Hence, new approaches are needed to overcome the problems in detecting C-terminal peptides, protein methylation and certain phosphosites.
strongly impaired at modified (for example, methylated) basic residues. Such missed cleavages increase peptide length and charge, resulting in complex fragmentation spectra that hinder identification of the peptide and methylation sites 2 . Lysine and arginine methylation is an important epigenetic and regulatory mechanism for protein-protein interactions and protein function in transcription, DNA repair and signaling 6 . Hence, new approaches are needed to overcome the problems in detecting C-terminal peptides, protein methylation and certain phosphosites.
New proteases to complement trypsin are much sought after for identification of alternate splice forms and the 3,844 'missing' proteins that lack proteomic evidence for their occurrence in human tissues 7 . One such protease is LysN, which selectively hydrolyzes peptidyl-lysine bonds and so leaves a lysine at the peptide N terminus. This results in strong b-ion series during CID 2 and c-ion series during electron-transfer dissociation fragmentation, enabling de novo ladder sequencing of peptides 8 . LysN digestion also identifies peptides missed in tryptic digests 9 , allows for enrichment of post-translationally modified peptides based on peptide charge 10 and cuts before methylated lysines 11 . However, these benefits are restricted to those LysN-generated peptides not containing internal arginines or peptides without lysine miscleavage, which are reported to be 13% (ref. 12) . Moreover, only 71% of all LysN cleavage sites contain an N-terminal lysine, pointing to poor specificity compared with that of trypsin 12 . Thus, we sought a protease to address these needs and report the characterization of LysargiNase, a metalloproteinase from the Archaea species M. acetivorans. We changed the original name ulilysin 13 to reflect its high N-terminal selectivity for lysine in addition to its previously described peptidylarginine specificity 13, 14 . LysargiNase mirrors trypsin in specificity and overcomes the limitations of LysN in controlled N-terminal placement of basic residues, with the added advantage of cleaving N-terminal to methylated forms of arginine and lysine, thereby generating shorter, less complex peptides.
We compared LysargiNase and trypsin digests of human breast cancer cells (line MDA-MB-231) using high-resolution tandem mass spectrometry (MS/MS). We identified cleaved peptides in a stringent and unbiased manner using nonspecific database searches, i.e., spectra-to-sequence matching was not restricted by prior information on preferred cleavage sites. 1,096 unique peptides from LysargiNase digests and 1,789 unique tryptic peptides were identified (n = 4) (Supplementary Table 1 ). By extracting the sequence surrounding the peptide termini, we derived 1,917 and 3,235 unique LysargiNase and trypsin cleavage sites, respectively. LysargiNase showed high sequence specificity: 92% to improve proteome coverage and protein c-terminal identification, we characterized the Methanosarcina acetivorans thermophilic proteinase Lysarginase, which cleaves before lysine and arginine up to 55 °c. unlike trypsin, Lysarginasegenerated peptides had n-terminal lysine or arginine residues and fragmented with b ion-dominated spectra. this improved protein c terminal-peptide identification and several argininerich phosphosite assignments. notably, cleavage also occurred at methylated or dimethylated lysine and arginine, facilitating detection of these epigenetic modifications.
Lysarginase mirrors trypsin for protein c-terminal and methylation-site identification
Proteomic identification of proteins and post-translational modifications requires proteolytic digestion of proteins into peptides for fragmentation by tandem mass spectrometry and identification through spectra-to-sequence matching. The cleavage specificity of the digestion enzyme determines peptide length, mass-tocharge ratio, and sequence and charge position. Trypsin is the most commonly used digestion enzyme in proteomics 1 . Cleaving after arginine and lysine, trypsin generates peptides that have a C-terminal positively charged residue in addition to an N-terminal positive charge from the α-amine. This charge distribution results in sequence-informative collision-induced dissociation (CID) fragmentation spectra dominated by y-type ions 1,2 . However, not all peptides are identified after trypsin digestion: protein C-terminal peptides inherently lack basic residues and are therefore rarely identified without selective enrichment 3, 4 , which leads to loss of biologically important information on protein structure and function 5 . In addition, cleavage after basic residues in the most common phosphosites, for example, (R or K) n (X)(S or T), can result in ambiguous phosphosite localization. Tryptic cleavage is also of LysargiNase cleavage sites were before arginine (40%), as previously reported 13, 14 but, notably, also before lysine (52%) (Fig. 1a) . In contrast, 91% of tryptic cleavages were after arginine (39%) or lysine (52%). Thus, LysargiNase mirrored trypsin cleavage specificity. The number of peptide identifications was improved when we applied the new specificity information to restrict the search space during spectrum-to-sequence assignment with 2,956 LysargiNase peptides (Supplementary Table 2 ) and 4,203 tryptic peptides identified (Supplementary Table 3 ). As with trypsin 15 , basic residues in missed LysargiNase cleavage sites were frequently preceded or followed by proline ( Supplementary  Fig. 1 ). LysargiNase fidelity also compared favorably to the lysine content (71%) at cleavage sites reported for LysN 12 . However, as LysN-generated peptides frequently contain internal arginine or miscleaved lysines, experimentally observed LysN peptides are longer on average: 18.0 residues in length 12 , versus 14.2 residues for LysargiNase.
Confirming the applicability of LysargiNase for proteomics, we found that LysargiNase was active in a variety of conditions and solvents commonly used in sample preparation and at dilutions down to 1:100 enzyme/proteome ratios (Supplementary Fig. 2 ). We used a dilution of 1:50 because it represents a similar molar ratio to 1:100 trypsin, enabling a fair comparison. LysargiNase showed notable thermophilicity at 55 °C, retaining 100% activity relative to that observed at 25 °C, which aids digestion by maintaining denaturation (Supplementary Fig. 2f ). LysargiNase exhibited tri-, di-and moderate carboxypeptidase activity at lysine or arginine residues using synthetic peptides (Supplementary Fig. 3 ).
Yet, when trypsin-digested BSA was used as substrate, only two of ten peptides were processed at their carboxy terminus and no amino-or diaminopeptidase activity was observed ( Supplementary Fig. 4) . LysargiNase proved suitable for in-gel digestion of β-casein and BSA (Supplementary Fig. 5 ).
LysargiNase aided peptide identification and hence proteome coverage by several means. After CID ion-trap fragmentation, fragment-ion sequences retaining the basic residue were very different when generated with LysargiNase versus trypsin. Whereas spectra of LysargiNase-cleaved peptides had a strong b-ion series, corresponding spectra of tryptic peptides identified with identical cleavage-site basic residues were dominated by y-type fragment ions (Fig. 1b and Supplementary Figs. 6 and 7) . This led to different coverage of the precursor peptide sequence (Fig. 1c) and resulted in different search-engine scores, i.e., different probabilities of correct sequence assignment. Second, corresponding peptides can differ where the cleavage-site basic residue is different (Supplementary Fig. 8 ), which can also alter peptide ionization and fragmentation 1 . However, fragment ions of the y series are more stable than b ions 16 , resulting in more tryptic peptide identifications than from LysargiNase (Supplementary Fig. 6b ). Indeed, we observed extensive a-ion fragments, likely arising from b ions, in a LysargiNase digest analyzed by beam-type CID fragmentation (Supplementary Fig. 9a ). Including these a ions in Comet XCorr scoring significantly increased quality (P < 0.0001, two-sided t-test) but not the number of LysargiNase peptide identifications (Supplementary Fig. 9b ). Complementary use of both proteases increased proteome coverage-1,347 unique peptide and 75th percentiles; whiskers extend to the 5th and 95th percentiles; dots, outliers. Significance of differences was tested using the two-tailed Student′s t-test (***P < 0.001).
(e) Phosphorylation motifs in trypsin-and LysargiNase-digested proteomes identified by the tool motif-x. Shown are the number and percentage of matching high-confidence phosphopeptides identified by MaxQuant at an FDR <0.01 with a localization probability >0.75. Phosphosites matching selected kinase specificity as extracted from the human protein reference database is shown as heat maps. Significance of differences was tested using Pearson's χ 2 test (*P < 0.05, **P < 0.01). Fig. 6b ).
A considerable overlap in peptide identifications (n = 1,558) resulted from the complementary fragmentation spectra, thereby increasing confidence in identification of these sequences. Finally, LysargiNase peptides included significantly more protein C-terminal peptides in four independent experiments by now having a lysine or arginine at their N termini compared with those generated by trypsin, in which all basic residues are lost (P < 0.001; We TiO 2 -enriched phosphopeptides labeled via SILAC (stableisotope labeling by amino acids in cell culture) from MDA-MB-231 cells. The identified phosphosites were stringently filtered for those with a MaxQuant localization-site probability >0.75 (ref. 17) , and phosphorylation motifs were determined using MotifX 18 . Compared with tryptic phosphopeptides, LysargiNasegenerated phosphopeptides showed a higher representation of RXS and RXXSP sites and phosphorylation motifs containing proline ( Fig. 1e and Supplementary Figs. 11 and 12) . Thus, LysargiNase benefits detection of sites phosphorylated by certain kinases: for example, protein kinase C, ERK and CDK5, which prefer RXS and RXXSP motifs 17 . After 5-and 20-min stimulation with 12-O-tetradecanoylphorbol-13-acetate, phosphopeptides with these sites accumulated ( Supplementary  Fig. 11 ), a result consistent for stimulation of the protein kinase C family 19 .
We verified the LysargiNase cleavage specificity by proteomic identification of protease cleavage sites (PICS), which determines cleavage sites after incubation with database-searchable proteomederived peptide libraries generated by chymotrypsin ( Fig. 2a) and GluC (Fig. 2b) digestion and subsequent dimethylation of lysine ε-amines before addition of LysargiNase or trypsin 20 . The dimethyl-lysine modification restricted trypsin cleavage to arginine residues as reported 20 , whereas LysargiNase also cleaved before the dimethylated lysines. Using matrix-assisted laser desorption/ionization (MALDI)-time-of-flight (TOF) mass spectrometry, we verified this flexible specificity by demonstrating cleavage of synthetic peptide substrates containing dimethylated lysine but not acetylated lysine (Fig. 2c) . Further confirmation came from LysargiNase digestion of dimethylated Escherichia coli proteome (n = 2) in which 49% and 43%, respectively, of the beam-type CID-identified peptides were cleaved before dimethylated lysine. In comparison, only 5% and 6% of tryptic peptides had a C-terminal dimethylated lysine (Supplementary Table 6 ). In MDA-MD-231 cell lysates, we also identified natural monoand dimethylated N-terminal lysines after LysargiNase digestion (Supplementary Figs. 13 and 14) . Thus, LysargiNase accepts unmodified, mono-and dimethylated lysine at P1′ as shown in the structural model (Supplementary Fig. 15 ) but kinetically prefers unmodified lysine.
This unusual tolerance of methylated lysines is noteworthy as it is challenging to identify such peptides owing to the presence of highly charged and often long tryptic peptides arising from missed cleavages 6 . Therefore, we posited that LysargiNase would also cut at methylated arginine. We found that LysargiNase cleaved monoand dimethylated arginines in MDA-MD-231 proteome samples ( Supplementary Figs. 13 and 14) . This was further characterized using synthetic peptides containing monomethylated and asymmetric or symmetric dimethylated arginine (Fig. 2d) , whereas trypsin cut essentially only after unmodified arginine. Moreover, we observed a significantly higher number of peptides containing a methylated (P < 0.05, two-tailed Student's t-test) or dimethylated npg brief communications (P < 0.001) arginine or lysine in the LysargiNase-digested MDA-MD-231 sample as compared to in the trypsin-digested sample (Supplementary Fig. 15b) . Overall, the thermophilic LysargiNase is a powerful complement to trypsin in proteomics. methods Methods and any associated references are available in the online version of the paper.
Accession codes. ProteomeXchange: mass spectrometry raw data and associated peptide identification details are available under accession number PXD001113, PXD001114, PXD001121, PXD001122, PXD001378 and PXD001379. onLine methods LysargiNase purification and activation. Wild-type LysargiNase (alias ulilysin) from M. acetivorans was expressed and purified as the zymogen as described for the C269A mutant 13 . Aliquots of proLysargiNase were activated by stepwise addition of 10 mM CaCl 2 buffered in 50 mM HEPES, pH 7.5, and incubated for 12-16 h at 20 °C.
Characterization of LysargiNase activity. LysargiNase activity was assayed with resorufin-labeled casein (Universal Protease Substrate, UPS) at an enzyme: substrate ratio of 1:400 in 50 mM HEPES, 10 mM CaCl 2 , pH 7.5, with varying concentrations of chemicals and solvents commonly used in proteomics added as indicated (Supplementary Figs. 1 and 2) . Assays were performed for 30 min at 37 °C or at the temperatures shown in the figure and stopped by addition of 5% TCA, followed by neutralization with 1.5 M Tris-HCl, pH 9.0. Fluorescence was measured using an excitation wavelength of 544 nm and emission wavelength of 590 nm on a fluorescence microplate reader (Molecular Devices fmax). These assay conditions were designed to generate less than 50% of the maximal fluorescence in the control reactions without added chemicals (data not shown) so as to quantify the effect of the different conditions. For proteome digestion efficiency assays, human MDA-MB-231 cell proteome was digested with LysargiNase (enzyme/substrate ratio 1:100) at 37 °C, 18 h in 50 mM HEPES,10 mM CaCl 2 , pH 7.5, and the chemicals as indicated in the figure. Digestion efficiency was visualized by 12% SDS-PAGE and Coomassie brilliant blue R250 staining.
MALDI-TOF-based exopeptidase activity assay.
Synthetic peptides were dissolved and diluted 1:100 in HPLC-grade water to a final concentration of 10 ng/µl. A tryptic BSA library was prepared by incubating 100 µg of BSA (Sigma) with 1.0 µg of Trypsin Gold (Promega) in 50 µl of 10 mM HEPES, 10 mM CaCl 2 , pH 7.5, 37 °C. The digestion was stopped before completion after 2 h by adding the serine protease inhibitor AEBSF (Sigma) to a final concentration of 1.0 mM. LysargiNase was incubated with synthetic peptides (10 ng) or 1 µg of the tryptic BSA mixture in 10 mM HEPES, 10 mM CaCl 2 , pH 7.5, for 18 h at 37 °C. Reactions were stopped by adding trifluoroacetic acid (TFA) to a final concentration of 0.1%. One microliter of sample was spotted in duplicate on a MALDI target plate and mixed with the equal volume of α-cyano-4-hydroxycinnamic acid (CHCA) (5 mg/ml in 70% acetonitrile (ACN) and 0.1% TFA). Samples were desalted on-plate by two washes with 1.0 µl of ice-cold 0.1% TFA. Samples were analyzed using a Voyager-DE STR MALDI-TOF mass spectrometer (Applied Biosystems). Baseline reduction and noise removal were performed using Data Explorer version 4.5.
In vitro assays with synthetic peptide substrates. To test cleavage at modified lysine residues, we modified synthetic peptide K1 (sequence RSGTLTYEAVKQTTD, obtained from GenScript) by reductive dimethylation using isotopically light formaldehyde and sodium cyanoborohydride 21 or acetylated using NHS-activated acetate (Pierce). Unmodified or modified K1 peptides were incubated with LysargiNase or trypsin at a molar ratio of 1:100 in 50 mM HEPES, 5 mM CaCl 2 for 3 h at 37 °C. Cleavage at modified arginine residues was tested with peptide R1 (sequence WGGYSRGGYGGW), synthesized with unmodified, monomethylated, asymmetric dimethylated or symmetric dimethylated arginine. The four R1 peptides were incubated with LysargiNase or trypsin at a molar ratio of 1:50 in 50 mM HEPES, 5 mM CaCl 2 , pH 7.5, for 16 h at 37 °C. All peptide cleavage reactions were terminated by dilution with 25× excess of 5 mg/ml CHCA dissolved in 80% ACN, 0.1% TFA. Cleavage assays with synthetic peptide substrates were spotted on a MALDI target (1 µl of reaction mixture in 5 mg/ml CHCA in 80% ACN, 0.1% TFA), air dried and analyzed using a 4700 series MALDI-TOF/TOF mass spectrometer (Applied Biosystems) in positive ion reflector mode.
Modeling of protein structure. Structural models of the LysargiNase are based on the experimental crystal structure of the enzyme with an arginine-valine dipeptide occupying the S 1 ′ and S 2 ′ pockets (Protein Data Bank: 2CKI) 13 . Models were generated using the UCSF Chimera software suite 22 with LysargiNase displayed in standard orientation 23 .
Cell culture and proteome preparation. For shotgun experiments, MDA-MB-231 cells (ATCC), which previously tested negative for mycoplasma contamination, were cultured in DMEM (Gibco) supplemented with 10% Cosmic Calf Serum, 10,000 U/ml penicillin G and 100 µg/ml streptomycin and non-essential amino acids (Gibco). Cells were detached using Versene and gentle scraping, collected by centrifugation and lysed in 100 mM HEPES, 150 mM NaCl, 5 mM EDTA, pH 7.5, supplemented with protease inhibitors (cOmplete Protease Inhibitors, Roche) and phosphatase inhibitors (PhosStop, Roche). Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad). E. coli proteome preparation and digestion. E. coli strain K12 was grown in LB broth before harvesting by centrifugation. Cells were washed twice with 50 mM HEPES, pH 7.5, before snapfreezing in liquid nitrogen. Cells were lysed by thawing in 50 mM HEPES with added protease inhibitor cocktail (cOmplete Protease Inhibitors, Roche), pH 7.5, followed by sonication and centrifugation to remove cell debris. The soluble E. coli proteome was reduced and denatured in 2 M guanidine hydrochloride and 1 mM TCEP (60 min, 60 °C), followed by alkylation with 5 mM iodoacetamide (45 min, 60 °C, dark). Two aliquots of the E. coli proteome were further modified by reductive dimethylation with 25 mM sodium cyanoborohydride and 25 mM light formaldehyde 24 . Both modified and unmodified E. coli proteomes were digested with LysargiNase or trypsin in 50 mM npg HEPES, 10 mM CaCl 2 , pH 7.5, at an enzyme/proteome ratio of 1:100 (w/w), 37 °C, 18 h.
Shotgun proteome preparation.
Generally, proteome aliquots of approximately 1 mg were denatured by addition of 3.5 M guanidinium-HCl, 10 mM DTT (30 min, 65 °C) and alkylated using 50 mM iodoacetamide (30 min, 20 °C, in the dark), and purified by chloroform-methanol precipitation 25 . For shotgun proteomics experiments, precipitated proteins were dissolved in 50 mM NaOH, immediately diluted tenfold, and neutralized by addition of water and buffer to a final concentration of 50 mM HEPES, 10 mM CaCl 2 , pH 7.5. Proteins were digested with LysargiNase (proteome/enzyme ratio 50:1 w/w) or trypsin gold (Promega, 100:1 w/w) at 37 °C for 16 h. Note that this corresponds to an approximately equal mole enzyme/substrate ratio because the molecular mass of proLysargiNase (38.4 kDa) is almost twice that of trypsin (23.4 kDa). Digests were clarified by centrifugation, and an aliquot of 20 µg digested protein desalted using C18 Stage tips 26 .
Phosphopeptide enrichment. For phosphopeptide analysis, protein pellets were dissolved in 8 M urea, 2 M thioruea to avoid loss of phosphorylation at high pH, diluted fivefold with 50 mM HEPES, 10 mM CaCl 2 , pH 7.5, and digested with LysargiNase (50:1 w/w) or Trypsin Gold (Promega, 100:1 w/w) for 16 h at 30 °C. Digests were clarified by centrifugation, and peptides were acidified and desalted with a C18 cartridge (SepPak, Waters). Phosphopeptides were enriched from four independent unstimulated MDA-MB-231 cell proteomes and from cell proteomes of four independent 12-O-tetradecanoylphorbol-13-acetate stimulation experiments at 5 min and 20 min. At each point, two replicates were enriched from two independent MDA-MB-231 cell proteomes using custom-made TiO 2 tips as described 17 and two replicates were enriched using commercial TiO 2 phosphopeptide enrichment kit (Sigma). All peptide samples were desalted using C18 Stage tips 26 and stored on-tip until mass spectrometry analysis.
Proteomic identification of protease cleavage-site specificity (PICS). PICS was performed as described 27 . In brief, E. coliderived proteome peptide libraries were generated by digestion with GluC or chymotrypsin followed by amine-modification by reductive dimethylation. Libraries (200 µg) were incubated with trypsin or LysargiNase at an enzyme/peptide library ratio of 1:100 (w/w). Free N-terminal amine groups of fragment peptides, generated by substrate peptide cleavage, were tagged with an N-terminal redox-cleavable biotin moiety and enriched by streptavidin capture, eluted and desalted with C18 OMIX tips (Varian).
Mass spectrometry. For shotgun and phosphoproteomics experiments, peptides were eluted from Stage tips in mobile phase 80% ACN, 0.1% formic acid, SpeedVac concentrated to near-dryness and dissolved in approximately 20 µl mobile phase 2% ACN, 0.1% formic acid. Ten microliters were loaded on the column. Shotgun experiments were analyzed on a nanoHPLC systems (Thermo Scientific) coupled to an LTQ-Orbitrap hybrid mass spectrometer (LTQ-Orbitrap XL, Thermo Scientific, operated by the UBC Centre for High Throughput Biology) using a nanospray ionization source consisting of a fused-silica trap column (length, 2 cm; inner diameter, 100 µm; packed with 5-µm-diameter Aqua C-18 beads; Phenomenex), fused-silica fritted analytical column (length, 20 cm; inner diameter, 50 µm; packed with 3-µm-diameter Reprosil-Pur C-18-AQ beads; Dr. Maisch GmbH) and a silica gold-coated spray tip (20-µm inner diameter, 6-µm diameter opening, pulled on a P-2000 laser puller; Sutter Instruments; coated on EM SCD005 Super Cool Sputtering Device, Leica Microsystems). Buffer A consisted of 0.5% acetic acid, and buffer B consisted of 0.5% acetic acid and 80% ACN. Gradients were run from 0% B to 15% B over 15 min, then from 15% B to 40% B in the next 65 min, then increased to 100% B over 10 min period, held at 100% B for 30 min. The LTQ-Orbitrap was set to acquire a full-range scan at 60,000 resolution (m/z 350-1,800) in the Orbitrap and to simultaneously fragment the top five peptide ions in each cycle in the LTQ (minimum intensity 200 counts). Parent ions were then excluded from MS/MS for the next 180 s. The Orbitrap was continuously recalibrated against protonated (Si(CH 3 ) 2 O) 6 ; at m/z = 445.120025 using the lock-mass function 28 .
Enriched phosphopeptides were analyzed by nanoHPLC-MS/ MS using the LTQ-Orbitrap XL setup as above or with a hybrid quadrupole-Orbitrap mass spectrometer (QExactive, Thermo Scientific) coupled online with a RSLC nanoHPLC (Ultimate 3000, Thermo Scientific). Samples were loaded on a 100-µm, 2-cm nanoviper pepmap100 trap column (Thermo Scientific) in 2% ACN, 0.1% formic acid at a flow rate of 15 µl/min. Peptides were eluted and separated at a flow rate of 300 nl/min onto an RSLC nanocolumn 75 µm × 15 cm, pepmap100 C18, 3-µm 100-Å pore size (Thermo Scientific), with a linear ACN gradient from 2% to 24% in 0.1% formic acid for 25 min acid followed by a linear increase to 30% ACN in 0.1% formic acid over 5 min and additional increase up to 80% ACN in 0.1% formic acid over 5 min, followed by re-equilibration at 2% ACN. The eluent was nebulized and ionized using a nanoelectrospray source (Thermo Scientific) with a distal coated fused-silica emitter (New Objective) with a capillary voltage of 1.8-2.2 kV. The QExactive instrument was operated in the data-dependent mode to automatically switch between full-scan MS and MS/MS acquisition. Survey full-scan MS spectra (350-1,850 m/z) were acquired in the Orbitrap with 70,000 resolution (200 m/z) after accumulation of ions to a 3 × 10 6 target value with maximum injection time of 120 ms. Dynamic exclusion was set to 30 s. The ten most intense multiply charged ions (z ≥ 2) were sequentially isolated and fragmented in the octopole collision cell by HCD with a fixed injection time of 60 ms, 17,500 resolution and AGC target of 1 × 10 5 counts. A 2.7-Da isolation width was chosen. Underfill ratio was at 10%, and dynamic exclusion was set to 30 s. Typical mass spectrometric conditions were as follows: spray voltage, 2 kV; no sheath and auxiliary gas flow; heated capillary temperature, 275 °C; normalized HCD collision energy 27%.
E. coli proteome digests and PICS assays were analyzed using a quadrupole time-of-flight mass spectrometer (QStar XL, Applied Biosystems, operated by the UBC Centre for Blood Research Mass Spectrometry Suite) coupled on-line to an LC Packings capillary LC system (Dionex). Peptide samples were diluted in 0.3% formic acid, loaded onto a column packed with Magic C18 resin (Michrom Bioresources) and eluted using a 0-80% gradient of organic phase over 95 min. Buffer A was 2% ACN npg with 0.1% formic acid, and buffer B was 80% ACN, 0.1% formic acid. ESI ionization-tip ionization voltage was 25,000 V. MS data were acquired automatically using the Analyst QS software, v1.1 (Applied Biosystems) with information-dependent acquisition based on a 1-s MS survey scan from 350 m/z to 1,500 m/z, followed by up to 3 MS/MS scans of 2 s each. Nitrogen was used as the collision gas. An overview over all mass spectrometry experiments is provided in Supplementary Table 7 .
In-gel digestion. The standard proteins BSA and β-casein were resolved by 12% SDS-PAGE. Bands were stained with Coomassie G-250 and then excised, destained thrice with 60% ACN, 20 mM ammonium bicarbonate, washed in 100% ACN and lyophilized. Gel bands were rehydrated with either 10 µl trypsin in 20 mM ammonium bicarbonate (12 ng/µl) or 10 µl LysargiNase (40 ng/µl) passive diffusion for 1 h, 4 °C. Excess solution was removed, and 10 µl 20 mM ammonium bicarbonate, 10 mM CaCl 2 was added to the gel plugs and digested overnight at 37 °C. Digests (1 µl on column) were analyzed by LC-MS/MS using an Agilent G4240A ChipCube interfaced directly to an Agilent G6550A Q-TOF mass spectrometer (Agilent Technologies). Peptides were diluted with buffer A (0.1% formic acid) and resolved by a 35-min linear gradient on a reversed-phase chip (75 µm × 150 mm, Zorbax 300SB-C18) from 3% buffer B (99.9% ACN, 0.1% formic acid) to 60% buffer B at 300 nl/min. Peptides were ionized by ESI (1.8 kV), and mass spectrometry analysis was performed in positive polarity, with precursor ions detected from 350 to 1500 m/z. The top three ions per scan were selected for CID using a narrow (1.3 amu) exclusion window and an MS/MS scan rate of two spectra/s. Precursor ions were then excluded from further CID for 30 s. Data files were converted into .mgf files using Agilent MassHunter Qualitative Analysis B.06.00, and the files were searched using Mascot v2.4 (Matrix Science). Search parameters included 0.3-Da tolerance for MS and MS/MS, UniProt-Swiss-Prot database with "all entries" enabled, variable oxidation of methionine, variable propionamide of cysteine and a maximum of two missed cleavages.
Spectrum-to-sequence matching. Shotgun and phosphoproteomics data acquired with the Orbitrap XL and QExactive spectra were matched to peptide sequences in the human UniProt protein database (October 2013) with appended standard laboratory and common contamination protein entries and reverse decoy sequences (in total 177,324 entries) using the Andromeda algorithm 29 for fragment ions in QExactive data, carbamidomethylation of cysteine residues (+57.021464 Da), variable N-terminal modification by acetylation (+42.010565 Da) and variable methionine oxidation (+15.994915 Da). Nonspecific searches of proteome digest were performed to probe the cleavage site specificity of LysargiNase. Specific searches of the same data sets used {X|KR} and {KR|X} as simple cleavage site rules for LysargiNase and trypsin, respectively, additionally considered Arg and Lys methylation (+14.01565 Da) and dimethylation (+28.031300 Da) as variable modifications and allowed up to three missed cleavages. Phosphoproteome data analysis additionally considered variable phosphorylation (+79.966331 Da) at Ser, Thr and Tyr, and, in the case of 12-O-tetradecanoylphorbol-13-acetate stimulation experiments, triple-SILAC labeling (Arg +6.020129, Lys +4.025107 and Arg +10.008269, Lys +8.014199 for medium and heavy labels, respectively).
Peak lists of QSTAR XL data were created using the Analyst QS software v1.1 (Applied Biosystems) and converted to the mzXML format using msConvert. Spectra were matched to peptides sequences in the UniProt E. coli K12 proteome database (downloaded 22 November 2013) with appended standard laboratory and common contamination protein entries and reverse decoy sequences (9,134 entries total) using X! Tandem 31 (E. coli proteome data) or Mascot v2.3 and X! Tandem 31 (for PICS data) in conjunction with PeptideProphet 32 and iProphet 33 For analysis of a-type ions in beam-type fragmentation data, QStar. wiff files were converted to .mzXML using msConvert and used as input for the TransProteomic Pipeline v4.7 rev1. Data were searched with Comet 35 as part of TPP using 0.2-Da tolerance for MS and MS/MS, LysargiNase specificity {X|KR}, variable oxidation of methionine (+15.994915 Da), two missed cleavages, and scoring for y ions and b ions. Additionally, an independent search was used with a ions also included as part of the scoring. XCorr scores for peptide spectrum matches were extracted from pepXML files and compared to determine the a-ion scoring effect.
Data analysis. For shotgun proteomics peptide identifications, the sequence context surrounding the N and C termini of the identified peptides was extracted from the database. For determination of the cleavage site specificity, all peptide termini identified by database searches without enzyme constraints were considered as LysargiNase or trypsin cleavage sites unless they mapped to protein termini. This resulted in the definition of {X|KR} as cleavage specificity of LysargiNase that was used in all subsequent searches. b-ion and y-ion counts were extracted from the MaxQuant result files, and fragment coverage was calculated by dividing the number of matched ions by the sequence length.
Phosphorylation motives were extracted using the motif-x web service 18, 36 . Phosphorylated peptide identifications obtained in all experiments after digestion with trypsin or LysargiNase were searched separately using the following settings: foreground format: pre-aligned; central character: S; width: 15; occurrences: 20; significance: 0.000001; background: IPI human proteome. The motifs identified by the two motif-x searches were merged, and for each motif the number of occurrences within the pool of phosphorylated peptides identified in the LysargiNase and trypsin data sets were counted by regular-expression matching. For comparison of the proportion of each motif in the LysargiNase and trypsin npg data sets, the occurrence was calculated as percent difference, and significance was tested using Pearson's χ 2 P value. Only motifs describing at least 5% of the phosphorylated peptides identified by trypsin or LysargiNase digestion are reported.
To link observed phosphorylation motifs to kinase activity, we retrieved known kinase sequence specificities from HRPD v9 (ref. 37) . For each identified phosphorylation motif, all corresponding phosphorylation sites in our joint trypsin and LysargiNase data sets were counted and matched to kinase specificity by regular-expression search, and the percentage of sites potentially targeted by a specific kinase were calculated. Only kinases matching at least one of the phosphorylation-site motifs identified in the data set are reported.
Protease cleavage sites were inferred by database searches from the peptides identified by mass spectrometry, which represent the prime side cleavage products of substrate cleavages, using a web-based tool (available at http://clipserve.clip.ubc.ca/pics/) as described 27 . Cleavage site specificity logos were generated with the iceLogo web tool 38 using standard settings. Box plots were generated using the BoxPlotR web server 39 .
